New GLP-1 users who have not established a supplement routine yet are good candidates for Replenza
Tohoku J Exp Med 206:131139 Chiou H-YC, Lin M-W, Hsiao P-J, Chen C-L, Chiao S, Lin T-Y, Chen Y-C, Wu D-C, Lin M-H (2019) Dulaglutide modulates the development of tissue-infiltrating Th1/Th17 cells and the pathogenicity of encephalitogenic Th1 cells in the central nervous system
The STEP 9 trial found that semaglutide reduced both body weight and knee osteoarthritis pain compared to placebo [24], and a large observational study using data from the Shanghai Osteoarthritis Cohort found that people on GLP-1 receptor agonists had a significantly lower rate of knee surgery, 1.7 percent compared to 5.9 percent in the non-GLP-1 group, with weight loss accounting for about 32 percent of that protective effect [22]
EoL can be quantified in several ways: Capacity fading is based on a given percentage drop in the battery capacity compared to its rated capacity under specified conditions
And, its a superior protein for a shake, without going Super Bass-o-Matic '76 style